Related references
Note: Only part of the references are listed.Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up Study
Jan C. Holter et al.
PLOS ONE (2016)
Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England
Albert Jan van Hoek et al.
PLOS ONE (2016)
Relation of Cardiac Complications in the Early Phase of Community-Acquired Pneumonia to Long-Term Mortality and Cardiovascular Events
Roberto Cangemi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Ten-Year Mortality after Community-acquired Pneumonia A Prospective Cohort
Dean T. Eurich et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands
Marie-Josee J. Mangen et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Association Between Hospitalization for Pneumonia and Subsequent Risk of Cardiovascular Disease
Vicente F. Corrales-Medina et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Outcomes in patients with community-acquired pneumonia admitted to the intensive care unit
Rodrigo Cavallazzi et al.
RESPIRATORY MEDICINE (2015)
Risk factors for hospital admission in the 28days following a community-acquired pneumonia diagnosis in older adults, and their contribution to increasing hospitalisation rates over time: a cohort study
Elizabeth R. C. Millett et al.
BMJ OPEN (2015)
A population-based study on the impact of hospitalization for pneumonia in different age groups
Vincenzo Baldo et al.
BMC INFECTIOUS DISEASES (2014)
Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia
Jordi Adamuz et al.
JOURNAL OF INFECTION (2014)
Etiology and outcome of severe community acquired pneumonia in immunocompetent adults
Ali Khawaja et al.
BMC INFECTIOUS DISEASES (2013)
Epidemiology and Long-term Clinical and Biologic Risk Factors for Pneumonia in Community-Dwelling Older Americans Analysis of Three Cohorts
Sachin Yende et al.
CHEST (2013)
US Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination
Marie R. Griffin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vaccines for preventing pneumococcal infection in adults
Sarah Moberley et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Clinical and economic burden of community-acquired pneumonia among adults in Europe
T. Welte et al.
THORAX (2012)
Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population
A. H. W. Bruns et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Angel Vila-Corcoles et al.
BMC INFECTIOUS DISEASES (2010)
Predicting mortality in the elderly with community-acquired pneumonia: should we design a new car or set a new 'speed limit'?
Veronica Brito et al.
THORAX (2010)
Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis
Sachin Yende et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Rising incidence and persistently high mortality of hospitalized pneumonia: a 10-year population-based study in Denmark
RW Thomsen et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002
AM Fry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Explaining trends in hospitalizations for pneumonia and influenza in the elderly
PL Hebert et al.
MEDICAL CARE RESEARCH AND REVIEW (2005)
Pneumonia - Still the old man's friend?
V Kaplan et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Share Paper
